# Clinical Trial to Evaluate Papilocare® Gel Efficacy Into Repairment of Cervical Lesions Caused by HPV

> **NCT04210336** · NA · COMPLETED · sponsor: **Procare Health Iberia S.L.** · enrollment: 200 (actual)

## Conditions studied

- HPV Infection
- Lesion Cervix

## Interventions

- **DEVICE:** PAPILOCARE
- **DEVICE:** LACTIC ACID GEL

## Key facts

- **NCT ID:** NCT04210336
- **Lead sponsor:** Procare Health Iberia S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-07
- **Primary completion:** 2022-11-30
- **Final completion:** 2023-01-20
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2025-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04210336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04210336, "Clinical Trial to Evaluate Papilocare® Gel Efficacy Into Repairment of Cervical Lesions Caused by HPV". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT04210336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*